Differences in GLP-1 RA medication adherence across place-based variables in patients with diabetes living in Wisconsin
{{output}}
Background: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications are efficacious in improving health outcomes in patients with type 2 diabetes mellitus (T2DM). As demand and costs have increased, questions have arisen ... ...
